Ventricular tachycardia (VT) commonly occurs in patients with structural heart disease and can be associated with an increased risk of sudden cardiac death. the cause, symptoms and prevention of Ventricular Arrhythmia (VA) and Sudden Cardiac Death (SCD) will be discussed in the VT and SCD session.
Topics like cardiometabolic alterations and its interactions between a variety of risk factors, cardiometabolic diseases including heart disease, diabetes mellitus and chronic renal failure, detection of the presence of cardiometabolic risk factors, prevention of cardiometabolic outcomes in adulthood, cardiometabolic health of children and adolescents influenced by lifestyle behaviors will be discussed in this Cardiometabolic Health session.
This Coronary Artery Disease session will clinical emphasis, observational studies, clinical trials, cardiac imaging, pharmacology, novel translational research on coronary artery disease along with epidemiology and prognosis.
Pulmonary Hypertension session will cover diagnosis, treatment and novel advanced research on major categories like pulmonary arterial hypertension, chronic thromboembolic pulmonary hypertension, and pulmonary hypertension due to left heart and lung diseases.
This Cardio-oncology and Cardiac Imaging session will cover emerging therapies in cardio-oncology, including ICI, targeted therapies and CAR T-cell, surveillance for cardiotoxicity and approach to therapy in patients with cardiotoxicit, cardiometabolic syndrome and cardiovascular risk factors in cancer survivors, cardio-protective strategies in cancer therapy and advanced research on invasive and non-invasive cardiovascular imaging including echocardiography, computed tomography, magnetic resonance, nuclear and X-ray imaging, etc.
Covid 19 and Heart Failure session will cover the relationship between heart failure (HF) and coronavirus disease (COVID 19), consequence of myocardial injury and cardiovascular (CV) complications, myocarditis and association of COVID-19 with both systolic and diastolic LV dysfunction, with LV diastolic impairment, pulmonary hypertension, and right ventricular dysfunction.
Advances in Echocardiography Technology session will cover the conventional clinical applications of cardiovascular ultrasound to the newer techniques with emerging clinical applications.
Different antithrombotic medications, various antiplatelet and anticoagulant therapies and their combinations in patients will be discussed in Antiplatelet Therapy and Anticoagulation session.
Current and future aspects of AI and machine learning in cardiology and cardiovascular medicine will be discussed in this AI in Cardiology session including cardiovascular signal processing, cardiovascular image processing, clinical decision support systems, wearable and portable sensors, assessment of noninvasive indexes of cardiovascular risk, cardiac monitoring.
Cardiovascular Rehabilitation session will cover exercise training, cardiac risk factor modification, psychosocial assessment, outcomes assessment, prescription, behavioral medicine, and cardiopulmonary risk factor management.
Copyright 2023 @ Keynote Connect